Evolution of the Average Target: Cerence Inc.

Evolution of the Target Price: Cerence Inc.

Changes in Analyst Recommendations: Cerence Inc.

27bc85c60e30cc2c8a049b1d.V20Se8TV-J8TxvfNML5VP9Q85fvahKZvv8uabJsHpCI.Mll8LY-vvKp1vrKPVdoscphsi7-_tugs4PrRIfEw6BMgKHgf9IGg7iGwlA~0602ade1ea0b88309af104ac245b4a32
25-08-06 Cerence Q3 revenue beats expectations RE
25-01-22 Needham Upgrades Cerence to Buy From Hold, $16 Price Target MT
24-07-15 Evercore ISI Adjusts Cerence's Price Target to $5 From $8, Maintains In Line Rating MT
24-07-12 Baird Adjusts Price Target on Cerence to $6 From $8, Maintains Neutral Rating MT
24-05-10 Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating MT
24-05-10 Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating MT
24-05-10 Wells Fargo Downgrades Cerence to Equalweight From Overweight, Price Target at $6.50 MT
24-04-17 Baird Adjusts Price Target on Cerence to $15 From $17, Maintains Neutral Rating MT
24-02-07 Wedbush Raises Cerence's Price Target to $21 From $19 After Higher-Than-Expected Fiscal Q1 Results, Keeps Neutral Rating MT
24-02-07 Craig-Hallum Downgrades Cerence to Hold From Buy, Price Target is $22 MT
23-11-29 Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Lower Outlook; Maintains Neutral Rating MT
23-11-29 Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Cut to Multi-Year Outlook, Lower Peer Multiples; Neutral Rating Kept MT
23-11-28 Wells Fargo Cuts Cerence's Price Target to $25 From $32, Maintains Overweight Rating MT
23-11-28 Needham Adjusts Cerence's Price Target to $23 From $34, Keeps Buy Rating MT
23-11-28 Wedbush Cuts Cerence's PT to $19 From $31 on Lower Multiple, Says Large Legacy Contract Write-Down to Overshadow Fiscal Year 2024 Guidance; Keeps Neutral Rating MT
23-08-09 Wedbush Raises Cerence's Price Target to $31 From $26 After Higher-Than-Expected Fiscal Q3 Results, Keeps Neutral Rating MT
23-05-11 Wedbush Cuts Cerence's Price Target to $26 From $32, Keeps Neutral Rating MT
23-05-10 Goldman Sachs Adjusts Price Target on Cerence to $28 From $31, Maintains Neutral Rating MT
23-02-10 Wedbush Raises Cerence's Price Target to $32 From $25 After Above-Street Fiscal Q1 Results, Keeps Neutral Rating MT
23-02-09 Goldman Sachs Adjusts Price Target on Cerence to $31 From $19, Maintains Neutral Rating MT
23-02-09 Baird Adjusts Price Target on Cerence to $30 From $23, Maintains Neutral Rating MT
23-02-09 Wells Fargo Adjusts Price Target on Cerence to $32 From $25, Maintains Overweight Rating MT
23-02-09 Needham Adjusts Cerence's Price Target to $42 From $40, Keeps Buy Rating MT
23-02-09 Craig-Hallum Upgrades Cerence to Buy From Hold, Price Target is $40 MT
22-11-30 Goldman Sachs Raises PT on Cerence to $19 From $17 as Q4 Results Were "Modestly Above Consensus", Maintains Neutral Rating MT
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +28.7%
+49.54%
+40.36%
+30.17%
+33.89%
+74.64%
+85.9%
+69.54%
+41.93%
+34.33%
Average +48.90%
Weighted average by Cap. +49.07%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
7.770USD
Average target price
10.00USD
Spread / Average Target
+28.70%
High Price Target
12.00USD
Spread / Highest target
+54.44%
Low Price Target
8.000USD
Spread / Lowest Target
+2.96%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Needham & Co.
Wells Fargo Securities
Wedbush
Baird
Craig-Hallum
Goldman Sachs
Jefferies & Co.
Cowen
RBC Capital Markets
Berenberg Bank
Raymond James
Evercore ISI
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
7.770USD
Average target price
10.00USD
Spread / Average Target
+28.70%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRNC Stock
  4. Consensus Cerence Inc.